Monitoring Functional Variation in the Breast During Menstrual Cycle by Using Diffuse Optical Spectroscopy
1 other identifier
observational
13
1 country
1
Brief Summary
The purpose of this study is to do determine the changes in physiological and optical properties in healthy pre-menopausal breast tissue during the menstrual cycle using Diffuse Optical Spectroscopy. The Researcher can determine 1) how large variations in breast tissue components are 2) how predictable and repeatable these variations are 3) the effects of endogenous hormones on breast tissue physiology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2006
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2006
CompletedFirst Submitted
Initial submission to the registry
October 4, 2007
CompletedFirst Posted
Study publicly available on registry
October 8, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2012
CompletedOctober 20, 2022
October 1, 2022
6.7 years
October 4, 2007
October 19, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Breast Tissue Physiology
Changes in physiological and optical properties in healthy pre-menopausal breast tissue during the menstrual cycle
4 weeks
Study Arms (1)
Diagnostic Tool
Changes in physiological and optical properties in healthy pre-menopausal breast tissue during the menstrual cycle using Diffuse Optical Spectroscopy
Interventions
Changes in physiological and optical properties in healthy pre-menopausal breast tissue during the menstrual cycle using Diffuse Optical Spectroscopy
Eligibility Criteria
primary care clinic, community sample
You may qualify if:
- Pre-Menopausal female 18 years of age or older with normal breast tissue
- Undergoes regular menstrual cycle cycles that do not vary by more than 5 days
You may not qualify if:
- Peri-Menopausal and Post-Menopausal
- Subjects taking oral contraceptives or any birth control medications in the past six months
- Diagnosed with breast cancer or cancer survivor,a history of breast surgery
- Subjects taking light sensitive drugs for photodynamic therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beckman Laser Institute University of California Irvine
Irvine, California, 92612, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Bruce J Tromberg, Ph.D
Beckman Laser Institute University of California Irvine
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Bruce Tromberg,Ph.D.,Director, Beckman Laser Institute and Medical Clinic and Professor, Departments of Biomedical Engineering and Surgery
Study Record Dates
First Submitted
October 4, 2007
First Posted
October 8, 2007
Study Start
February 1, 2006
Primary Completion
October 1, 2012
Study Completion
October 1, 2012
Last Updated
October 20, 2022
Record last verified: 2022-10